02/09/2014 07:59:14 Free Membership Login

Map Pharmaceuticals Plans FDA Meeting To Discuss Manufacturing Issues

Date : 04/12/2012 @ 5:32PM
Source : Dow Jones News
Stock : Allergan, (AGN)
Quote : 163.68  1.57 (0.97%) @ 4:00AM
Allergan share price Chart

Map Pharmaceuticals Plans FDA Meeting To Discuss Manufacturing Issues

Map Pharmaceuticals, Inc. (MM) (NASDAQ:MAPP)
Historical Stock Chart

3 Years : From Sep 2011 to Sep 2014

Click Here for more Map Pharmaceuticals, Inc. (MM) Charts.

Map Pharmaceuticals Inc. (MAPP) plans to meet with the Food and Drug Administration during the current quarter to discuss manufacturing issues that are preventing approval of its migraine medication Levadex.

The FDA in March sent a complete response letter to the biopharmaceutical company that required Map Pharmaceuticals to address manufacturing issues, chemistry and controls issues found in an inspection of the drug maker's third-party manufacturer.

Investors have been awaiting the agency's decision on the usability of Map's inhalable drug, which delivers a common migraine treatment in an aerosol format.

President and Chief Executive Timothy S. Nelson said the company continues to work closely with partner Allergan Inc. (AGN), as it seeks to resolve the issues as quickly as possible. Allergan has a deal with Map Pharmaceuticals to jointly promote Levadex.

The company also announced that it recently was issued a third patent related to Levadex.

Map shares closed Thursday at $13.14, down 1.2%, and were inactive in after-hours trading. The stock is off nearly 27% from a 2-year high last month before the company received the FDA's complete response letter.

 
   -By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com 


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us 140902 07:59